[
  {
    "criterion": "The assistant provides a clear and concise justification for combining the two immunotherapies despite limited data.",
    "axis": "communication_quality",
    "point": 5
  },
  {
    "criterion": "The assistant acknowledges the absence of robust clinical trials and emphasizes the need for close monitoring.",
    "axis": "completeness",
    "point": 8
  },
  {
    "criterion": "The assistant fails to mention potential risks associated with combining immunotherapies, such as cytokine release syndrome.",
    "axis": "accuracy",
    "point": -6
  },
  {
    "criterion": "The assistant does not address the patient's overall status, tolerance of previous therapies, and willingness to enroll in an investigational protocol.",
    "axis": "completeness",
    "point": -4
  },
  {
    "criterion": "The assistant uses technical jargon and does not provide a clear explanation of the immunotherapy mechanisms.",
    "axis": "communication_quality",
    "point": -2
  },
  {
    "criterion": "The assistant recommends combining the two immunotherapies without considering the patient's previous response to single-agent therapy.",
    "axis": "accuracy",
    "point": -8
  },
  {
    "criterion": "The assistant does not provide a clear plan for managing severe adverse events if they occur.",
    "axis": "completeness",
    "point": -5
  },
  {
    "criterion": "The assistant suggests enrolling the patient in an investigational protocol without considering the potential risks and benefits.",
    "axis": "completeness",
    "point": -3
  },
  {
    "criterion": "The assistant does not provide any justification for attempting combination therapy over monotherapy.",
    "axis": "completeness",
    "point": -7
  }
]